KAM
OMED

Kazazian Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Kazazian Asset Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-31,475
Closed -$67K – 105
2018
Q3 		$67K Buy
31,475
+10,972
+54% +$23.4K 0.06% 91
2018
Q2 		$47K Sell
20,503
-786
-4% -$1.8K 0.04% 85
2018
Q1 		$68K Buy
21,289
+1,777
+9% +$5.68K 0.07% 81
2017
Q4 		$80K Buy
+19,512
New +$80K 0.08% 77